Allergy, Asthma and Clinical Immunology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
AllerGen’s 8th research conference
2016
-
President's message
2007
-
Focused allergic rhinitis practice parameter for Canada.
20:45.
2024
-
A survey of severe asthma in Canada: results from the CASCADE practice reflective program.
20:31.
2024
-
A case of pediatric serum sickness like reaction (SSLR) after a 2-month re-exposure to amoxicillin.
20:29.
2024
-
Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature.
19:85.
2023
-
A case of possible anaphylaxis to ASA and structurally unrelated NSAIDs.
19:81.
2023
-
Autoinflammatory gene mutations associated with eosinophilia and asthma.
19:76.
2023
-
Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who survive.
19:58.
2023
-
Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study.
19:54.
2023
-
A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis.
19:48.
2023
-
Recommendations from a Canadian Delphi consensus study on best practice for optimal referral and appropriate management of severe asthma.
19:12.
2023
-
Allergen bronchoprovocation: correlation between FEV1 maximal percent fall and area under the FEV1 curve and impact of allergen on recovery.
19:8.
2023
-
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis.
19:7.
2023
-
Geographical discrepancy in oral food challenge utilization based on Canadian billing data.
19:5.
2023
-
International recommendations on epinephrine auto-injector doses often differ from standard weight-based guidance: a review and clinical proposals.
18:102.
2022
-
CFTR heterozygosity in severe asthma with recurrent airway infections: a retrospective review.
18:46.
2022
-
Lessons learned in allergy and immunology training: a survey analysis.
18:7.
2022
-
Modified oral food challenge protocol approach in the diagnosis of Food Protein-Induced Enterocolitis Syndrome.
18:8.
2022
-
Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research Network.
18:32.
2022
-
Telemedicine in allergy/immunology in the era of COVID-19: a Canadian perspective.
18:16.
2022
-
The need for a food allergy educator program for allied healthcare professionals in Canada.
18:62.
2022
-
Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study.
18:70.
2022
-
CSACI position statement: transition recommendations on existing epinephrine autoinjectors.
17:130.
2021
-
Comparison of weight per volume and protein nitrogen units in non-standardized allergen extracts: implications for prescribing subcutaneous immunotherapy.
17:92.
2021
-
Demographic characteristics associated with food allergy in a Nationwide Canadian Study.
17:72.
2021
-
Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report.
17:58.
2021
-
Liver enzyme elevation and eosinophilia with atorvastatin: a case of probable DRESS without cutaneous symptoms.
17:81.
2021
-
Neonatal abstinence syndrome is a potential cause of low TREC copy number.
17:115.
2021
-
Practical challenges in oral immunotherapy resolved through patient-centered care.
17:31.
2021
-
Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series.
17:125.
2021
-
Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling.
17:65.
2021
-
Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts.
17:3.
2021
-
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada.
17:108.
2021
-
The pharmacokinetics of epinephrine/adrenaline autoinjectors.
17:25.
2021
-
Underestimation of airway luminal eosinophilia by quantitative sputum cytometry.
17:63.
2021
-
A contemporary look at allergic conjunctivitis.
16:5.
2020
-
A single centre retrospective study of systemic reactions to subcutaneous immunotherapy.
16:93.
2020
-
Adults with possible food protein-induced enterocolitis syndrome with crustacean ingestion.
16:99.
2020
-
CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy.
16:20.
2020
-
Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review.
16:41.
2020
-
Correction to: The International/Canadian Hereditary Angioedema Guideline.
16:33.
2020
-
Epinephrine auto-injector needle length.
16:24.
2020
-
Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review.
16:72.
2020
-
Changing the culture is a marathon not a sprint.
15:8.
2019
-
Omalizumab in patients with severe asthma and persistent sputum eosinophilia.
15:21.
2019
-
The International/Canadian Hereditary Angioedema Guideline.
15:72.
2019
-
Use of a vibrating mesh nebulizer for allergen challenge.
15:73.
2019
-
Whole blood vs PBMC: compartmental differences in gene expression profiling exemplified in asthma.
15:67.
2019
-
A multi-stakeholder perspective on asthma care in Canada: findings from a mixed methods needs assessment in the treatment and management of asthma in adults.
14:36.
2018
-
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens.
14:1.
2018
-
Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective.
14:68.
2018
-
Loss of bronchoprotection to Salbutamol during sputum induction with hypertonic saline: implications for asthma therapy.
14:26.
2018
-
Unintentional injection to the bone with a pediatric epinephrine auto-injector.
14:32.
2018
-
Allergen-specific immunotherapy.
14:53.
2018
-
Allergic rhinitis.
14:51.
2018
-
An introduction to immunology and immunopathology.
14:49.
2018
-
Anaphylaxis.
14:54.
2018
-
Asthma.
14:50.
2018
-
IgE-mediated food allergy.
14:55.
2018
-
Introduction from the Editors.
14:48.
2018
-
Non-IgE-mediated food hypersensitivity.
14:56-56.
2018
-
Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy.
13:2.
2017
-
Asthma biomarkers in the age of biologics.
13:48.
2017
-
Consumer preferences for food allergen labeling.
13:19.
2017
-
Erratum to: Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?.
13:33.
2017
-
High rate of house dust mite sensitization in a shrimp allergic southern Ontario population.
13:5.
2017
-
Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.
13:38.
2017
-
Prediction of clinical peanut allergy status among children in Hamilton, Ontario using chart review data collected during 2012–2015.
13:10.
2017
-
Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations.
13:17.
2017
-
Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016.
13.
2017
-
Primum non nocere—first do no harm. And then feed peanut.
13:7-7.
2017
-
Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016.
13.
2017
-
Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?.
12:11.
2016
-
Proceedings of the Canadian society of allergy and clinical immunology annual scientific meeting 2015.
12:22.
2016
-
Proceedings of the Canadian society of allergy and clinical immunology annual scientific meeting 2015.
12.
2016
-
Allergen immunotherapy in pregnancy.
11:31.
2015
-
CSACI position statement: epinephrine auto-injectors and children < 15 kg.
11:20.
2015
-
CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma.
11:9.
2015
-
Insights and advances in chronic urticaria: a Canadian perspective.
11:7.
2015
-
The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies.
11:16.
2015
-
10th anniversary of allergy, asthma & clinical immunology.
10:51.
2014
-
A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma.
10:64.
2014
-
Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011.
10:38.
2014
-
Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy.
10:39.
2014
-
Blood biomarkers of the late phase asthmatic response using RNA-Seq.
10:A61-A61.
2014
-
Canadian hereditary angioedema guideline.
10:50.
2014
-
Children under 15 kg with food allergy may be at risk of having epinephrine auto-injectors administered into bone.
10:40.
2014
-
Co-exposure to allergen and diesel exhaust enhance inflammatory responses in human airway submucosa.
10:a57.
2014
-
Dietary exposures and allergy prevention in high-risk infants: a joint position statement of the Canadian Society of Allergy and Clinical Immunology and the Canadian Paediatric Society.
10:45.
2014
-
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis.
10:55.
2014
-
IL-4 and IL-13 regulate TLR expression and eosinophil-basophil differentiation of cord blood CD34+ progenitor cells.
10:a60.
2014
-
Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections.
10:22.
2014
-
Reconciliation of health records following penicillin allergy testing of hospitalized patients.
10:a39.
2014
-
Th17/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response.
10:32.
2014
-
The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC) - optimizing the Nasal Allergen Challenge (NAC) model.
10:a62.
2014
-
The early life gut microbiota and atopic disease.
10:A63-A63.
2014
-
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children.
10:53.
2014
-
Transcriptional networks in whole blood of asthmatics.
10:a58.
2014
-
Value of skin testing children with a family history of food allergy before ingestion of suspect food allergens.
10:a29.
2014
-
Are known biomarkers for asthma present in early infancy?.
10:A48-A48.
2014
-
Comparison of questionnaire responses with biomarkers of tobacco smoke exposure in a Canadian birth cohort at three months of age.
10:A60-A60.
2014
-
Th17/Treg ratio derived using DNA methylation analysis discriminates allergen-induced early from dual asthmatic responses.
10:A46-A46.
2014
-
Association between low vitamin D levels and the diagnosis of asthma in children: a systematic review of cohort studies.
10:31-31.
2014
-
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.
9:30.
2013
-
CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults.
9:24.
2013
-
Experiencing a first food allergic reaction: a survey of parent and caregiver perspectives.
9:18.
2013
-
Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings on microbiota composition and diversity.
9:15.
2013
-
Newly diagnosed chronic granulomatous disease in a 44 year old male presenting with recurrent groin cellulitis and colitis.
9:9.
2013
-
Proposed new mechanism for food and exercise induced anaphylaxis based on case studies.
9:11.
2013
-
The effects of rituximab on serum IgE and BAFF.
9:39.
2013
-
The utility of using fiberoptic rhinoscopy in the diagnosis of nasal polyps.
9:38.
2013
-
Local and systemic immunological parameters associated with remission of asthma symptoms in children.
8:16.
2012
-
Management of anaphylaxis in schools: Evaluation of an epinephrine auto-injector (EpiPen®) use by school personnel and comparison of two approaches of soliciting participation.
8:4.
2012
-
Skin prick testing with extensively heated milk or egg products helps predict the outcome of an oral food challenge: a retrospective analysis.
8:5.
2012
-
The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients.
8:7.
2012
-
Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.
7:13.
2011
-
Allergen-specific immunotherapy.
7:S5.
2011
-
Allergic rhinitis.
7:S3.
2011
-
An introduction to immunology and immunopathology.
7:S1.
2011
-
Anaphylaxis.
7:S6.
2011
-
Asthma.
7:S2.
2011
-
Canadian clinical practice guidelines for acute and chronic rhinosinusitis.
7:2.
2011
-
Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma.
7:8.
2011
-
Food allergy.
7:S7.
2011
-
Introduction from the Editors.
7:I1.
2011
-
Is breastfeeding protective against the development of asthma or wheezing in children? A systematic review and meta-analysis.
7:a11.
2011
-
The identification of eosinophilic gastroenteritis in prednisone-dependent eosinophilic bronchitis and asthma.
7:4.
2011
-
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.
6:24.
2010
-
Food allergy management from the perspective of patients or caregivers, and allergists: a qualitative study.
6:30.
2010
-
Food allergy management from the perspective of patients, caregivers and allergists: a qualitative study.
6:p8.
2010
-
Omalizumab: Practical considerations regarding the risk of anaphylaxis.
6:32.
2010
-
Online anaphylaxis training for schools is effective and feasible.
6:p5.
2010
-
Skin prick testing in patients using beta-blockers: a retrospective analysis.
6:2.
2010
-
Canadians' perception of food allergy risk.
6:p31.
2010
-
Estimating the prevalence of milk, egg, and wheat allergies in the Canadian population.
6:p37.
2010
-
Functional genomics of the peripheral blood response to allergen inhalation challenge.
6:p3.
2010
-
Assessing a community-based asthma education intervention.
6:p9.
2010
-
Assessing a population-based approach to the management of respiratory disease.
6:p11.
2010
-
Effectiveness study of an online anaphylaxis training program for school personnel: overview of methods for a pilot study in a large Canadian school board.
6:p12.
2010
-
Hodgkin's lymphoma presenting with markedly elevated IgE: a case report.
5:12.
2009
-
Psychological Factors in Asthma.
4:12-28.
2008
-
Psychological factors in asthma.
4:12-28.
2008
-
The mind-body of allergic diseases.
4:1.
2008
-
Immunotherapy with Allergen Peptides.
03:53-53.
2007
-
Immunotherapy with Allergen Peptides.
3:53-59.
2007
-
Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI).
2:47-61.
2006
-
Consensus Guidelines on Practical Issues of Immunotherapy–Canadian Society of Allergy and Clinical Immunology (CSACI).
02:47-47.
2006
-
Linear IgA dermatosis: An unusual case involving the oral mucosa and possible association with perindopril therapy.
5:203-208.
2000
-
Hemopoietic mechanisms in nasal polyposis and asthma.
5:233-236.
2000
-
Letter to the editor.
4:6.
1999
-
Stroke following intravenous immunoglobulin infusion in a 28-year-old male with common variable immune deficiency: A case report and literature review.
4:250-253.
1999
has subject area
Identity
International Standard Serial Number (ISSN)
-
1203-844X
-
1710-1484
-
1710-1492
Electronic International Standard Serial Number (EISSN)